Own Medibank (ASX:MPL) shares? Now you own a piece of this tech start-up

What new investment did Medibank announce today?

| More on:
a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Medibank has invested $10 million in virtual health  
  • The private health insurer's share price is making little impact today
  • Medibank shareholders have seen a 10% boost in returns in the past 12 months 

The Medibank Private Ltd (ASX: MPL) share price is making little headway today. It is currently flat at $3.21 having earlier jumped to $3.25.

For comparison, the S&P/ASX 200 Index (ASX: XJO) is up 1.15% at the time of writing.

However, there is an interesting piece of news out of Medibank today. The private health insurance company has announced a new multi-million investment in a health technology company.

Let's take a look.

Virtual health investment

Medibank has invested $10 million in the health technology company Medinet. The aim is to support the increasing role of virtual health in Australia.

Medinet is a digital platform providing patients with access to doctors online via video, audio, and chat. The platform was launched in 2019 and is being used in some GP clinics in Australia. The app is within the top five healthcare apps downloaded in the country.

Commenting on the investment, Medibank Group Executive – CEO Health Services Dr Andrew Wilson said:

People are looking for the same level of choice and convenience in their healthcare that they get in other parts of their lives. The COVID pandemic has accelerated the use and acceptance of technology-enabled healthcare, with recent research showing that 70% of Australians are willing to use virtual healthcare services.

Medinet's platform supports this by giving patients the ability to make an appointment and connect with a GP virtually, to access scripts and referrals generated during the consult, and to have their medication delivered straight to their home.

Credit Suisse has recently rated the Medibank share price as a "buy" with a $3.50 price target. Medibank increased operating profit by 12.3% in the first half of FY22, while net profit after tax (NPAT) descended 2.7%. Policyholder numbers climbed 1.5% in the half while jumping 3.3% in 12 months.

On March 24, Medibank will pay a dividend of 6.1 cents per share.

Medibank share price recap

The Medibank share price has climbed 10% in the past 12 months, but it has fallen 4% year to date.

For perspective, the benchmark ASX 200 index has leapt 7% in the past 52 weeks.

In the past month, Medibank shares are in the red by 0.3% but they have jumped by 5% in the past week.

Medibank has a market capitalisation of about $8.9 billion based on its current share price.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »